Celator Pharma Stock Price (NASDAQ:CPXX)

Add to My Stocks
$30.24 $0 (0%) CPXX stock closing price Jul 14, 2016 (Closing)
Prev Close* : $30.24
Market Cap:
$1.3B
Day Low: $0
52 Week Low: $1.12
Open: $0
Volume: $0
Day High: $0
52 Week High: $30.37
Dividend:
0.00

Latest Stock Market News

Latest Articles

Celator Pharma News - From Partners

CPXX Stockcharts

View CPXX PE ratio, PS ratio stocks charts and compare with peers.
CPXX Chart
Note: Compare Celator Pharma stock price history with the index and industry peers.

Celator Pharma Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
)
PB ratio (
price to book ratio
)

Celator Pharma Returns

ROE
(return on equity)

Celator Pharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

CPXX Industry Peers

Company Price Change (%)
Axogen (AXGN)43.90.05 (0.11%)
Relypsa (RLYP)31.990 (0%)
Ambit Biosciences (AMBI)15.60 (0%)
Cti Biopharma (CTIC)4.780.12 (2.45%)
Ambit Biosciences (AMBI)15.60 (0%)
Affirmed (AFMD)2.50 (0%)
Affirmed (AFMD)2.50 (0%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Progenics Pharma (PGNX)7.50.27 (3.73%)
Mallinckrodt (MNK)15.890.19 (1.21%)
Akorn (AKRX)14.040.06 (0.43%)
Top gainers from Medical-Generic Drugs industry
* As of May 22, 2018
CompanyPriceChange (%)
Teligent (TLGT)2.710.16 (5.57%)
Corium (CORI)8.510.42 (4.7%)
Adamas Pharma (ADMS)30.890.99 (3.11%)
Allergan (AGN)154.214.22 (2.66%)
Supernus Pharma (SUPN)551.1 (1.96%)
Aquinox Pharma (AQXP)12.510.17 (1.34%)
Dr. Reddy's Laboratories (RDY)28.960.36 (1.23%)
Top losers from Medical-Generic Drugs industry
* As of May 22, 2018

Celator Pharmaceuticals Inc Stock News - Partner Headlines

Celator Pharma Financial Statements

income statement20152014201320122011
Net Sales or Revenues-----
Net Income-19.31M-16.9M-20.84M-10.9M-14.15M
Total Operating Expense17.99M17.71M14.41M7.57M14.7M
View Celator Pharma income statement
balance sheet20152014201320122011
Total Assets25.63M35.11M27.47M13.43M6.62M
Total Liabilities19.1M13.21M4M6.58M4.06M
Shareholders Equity6.53M21.9M23.46M6.85M2.56M
View Celator Pharma balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) in Assets Liabilities1.39M--0.02M1.24M-1.63M
Net Cash from (used by) Operating Activities-15.49M-14.41M-12.45M-4.96M-14.6M
Increase (Decrease) in Prop Plant And Equipment-0.05M-0.06M-0.04M--0.09M
View Celator Pharma cash flow statement

Celator Pharma Stock Message Board

Celator Pharma stock price ended the last trading day at $30.24. The total market value as denoted by $1.3B for Celator Pharma, is the market value of the company's outstanding shares. Celator Pharma valuation can be guaged using various valuation metrics like the price to earnings ratio.

For recognizing and analyzing the real performance of Celator Pharma stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. 0 CPXX shares were traded yesterday, and Celator Pharma stock chart shows that the CPXX stock quote hit a day high of $0 and day low of $0. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Celator Pharma dividend per share was 0.00 during the last quarter. One can observe stock price trends and check for volatility by checking Celator Pharma stock price history.